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Abstract
Co-supplementation of ferrous salts with vitamin C exacerbates oxidative stress in the
gastrointestinal tract leading to ulceration in healthy individuals, exacerbation of chronic
gastrointestinal inflammatory diseases and can lead to cancer. Reactive oxygen and nitrogen species
(RONS) have been ascribed an important role in oxidative stress. Redox-active metal ions such as
Fe(II) and Cu(I) further activate RONS and thus perpetuate their damaging effects. Ascorbic acid
can exert a pro-oxidant effect by its interaction with metal ions via a number of established RONS
generating systems which are reviewed here. Further studies are required to examine the
detrimental effects of nutraceuticals especially in chronic inflammatory conditions which co-present
with anaemia.
Introduction
A growing public awareness of the benefits of a healthy
lifestyle has been accompanied by an explosive use of
nutraceuticals over the past decade. This has afforded the
opportunity for increased historical and planned trials of
the benefits and risks involved in taking supplements. In
particular, emphasis has been placed on the anti-oxidant
arsenal, which is an area that has been well studied but
ambiguous. A great many studies have been conducted on
the effects of anti-oxidant consumption after absorption
at the molecular level (for example in blood), but criti-
cally most have overlooked the initial deleterious effects
on the GI Tract.
Recently, vigorous debate has ensued regarding the toxic
side-effects of nutraceutical self-administration. The
health advantages of vitamin C have been widely
reported. Vitamin C has been shown to exhibit anti-oxi-
dant effects at low doses but conversely at high doses it
becomes a pro-oxidant [1]. Studies have shown that vita-
min C intake above the RDA frequently occurs and is
attributed to the increase in supplementation in addition
to dietary sources. A recent report gave vitamin C intake
levels with 1524% RDA (50 mg) in supplement users
however even in non-supplement users the recommended
levels were exceeded with an average intake of 210% [2].
A daily intake exceeding the RDA was also found for other
key nutrients such as iron. The daily intake of iron was
found to be 1874% of the published Korean RDA (18 mg)
for supplement users in comparison to 62% RDA for non-
supplement users. This dramatic finding pertained to
some one third of the population. Elevated ingestion of
ferrous iron leads to the generation of reactive oxygen and
nitrogen species (RONS), lipid peroxidation and oxida-
tive stress [3]. High tissue concentrations of iron are asso-
ciated with a number of pathologies including some
cancers, inflammation, diabetes, liver and heart disease
[4].
Despite these alarming figures, iron supplementation is
very common. It is often taken in conjunction with vita-
min C to aid absorption. The damaging effects of a high
intake of either iron salts or vitamin C alone warrants
Published: 16 January 2004
Nutrition Journal 2004, 3:2
Received: 12 November 2003
Accepted: 16 January 2004
This article is available from: http://www.nutritionj.com/content/3/1/2
© 2004 Fisher and Naughton; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted 
in all media for any purpose, provided this notice is preserved along with the article's original URL.Page 1 of 5
(page number not for citation purposes)
Nutrition Journal 2004, 3 http://www.nutritionj.com/content/3/1/2serious consideration. However, in tandem this cocktail is
potent. Uncontrolled interaction between vitamin C and
iron salts leads to oxidative stress. Many patients suffering
from diseases of the GI tract such as Crohn's disease and
ulcerative colitis often also present with iron deficiency
anaemia requiring co-supplementation of vitamin C and
iron. A great deal of interest has been shown in the effects
of iron supplementation on gastric function in patients
suffering from inflammatory diseases and in healthy indi-
viduals. Numerous studies have demonstrated iron-
induced increases in oxidative damage and disease sever-
ity in animal models of gastric inflammation [5-7]. In par-
ticular, studies have highlighted the induction of gastric
ulcers in rats by the injection of ferrous iron and ascorbic
acid [8]. However, ferrous iron or ascorbic acid, when
injected alone into the gastric wall did not produce pene-
trating ulcers. The authors propose that lipid peroxidation
mediated by oxygen radicals plays a critical role in ulcer
pathogenesis as treatment with superoxide dismutase sig-
nificantly decreased ulceration in tandem with peroxida-
tion. In a long-term study, an iron enriched diet affected
an increase in colorectal carcinoma in induced colitis in
mice [7].
In humans, a single clinical dose of ferrous sulfate has
been shown to induce oxidative damage in healthy indi-
viduals [9]. This study extends previous reports showing
iron induces enhanced lipid peroxidation in rats [8].
Using a double-lumen perfusion tube, perfusion with
saline containing ferrous sulphate resulted in some fifty
fold increases in lipid peroxidation as measured by thio-
barbituric acid reactive substances. Intriguingly, antioxi-
dant capacity increased some three-fold with iron
administration. In patients with Crohn's disease, treat-
ment with ferrous sulphate (120 mg for 7 days), increased
clinical symptoms of disease activity [10]. These results
clearly indicate that the unnatural concentration of iron
salts in a bolus dose accompanied by excess reducing vita-
min C can seriously compromise the epithelial lining of
the GI tract.
Mechanisms of Redox-Active Metal Ion 
Mediated RONS Formation
Ascorbic acid has a number of known interactions with
metal ions. These interactions involve redox reactions
including i) activation of molecular oxygen leading to oxi-
dation of endogenous aromatic moieties [Udenfriend's
system] [11,12], ii) the reduction reactions of Fe(III) to
Fe(II) facilitating their involvement in the activation of
peroxides [the Fenton reaction] [13], iii) metal ion cataly-
sis of the oxidation of ascorbic acid with concomitant for-
mation of hydrogen peroxide (H2O2) and potential
hydroxyl radical (•OH) generation [from Weissberger et
al.] [14-16].
Proposed mechanism for the generation of H2O2 via the oxidation of ascorbic acidFigure 1
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In chemical model systems, the Udenfriend system has
been demonstrated to hydroxylate aromatic compounds,
saturate hydrocarbons to alcohols and olefins to epoxides
[17]. It has been distinguished from the Weissberger sys-
tem in both the mechanism and type of oxidation prod-
ucts produced [17]. Udenfriend's system involves ascorbic
acid as a two-electron donor complexed to a transition
metal such as Fe(II) [11]. It is speculated that in the pres-
ence of O2, complexation between Fe(II) and ascorbic
acid results in the formation of an active oxygen species
speculated to be •OH [18]. The proposed mechanism
(Figure 1) shows the oxidation of ascorbic acid to dehy-
droascorbic acid, by electron transfer through Fe(II), and
subsequent hydroxylation of an aromatic compound
[19]. This reaction has been shown to be enhanced when
iron is coupled with a chelator for example in iron-citrate
complexes found within biofluids [20].
Fenton chemistry
The Fenton reaction involves the transition metal cata-
lyzed reduction of H2O2 to generate a powerful oxidizing
species. Transition metals have varying oxidation states,
and therefore they are able to catalyze oxidation and
reduction reactions. In the blood, circulating iron is
tightly bound to the protein transferrin, which reduces its
reduction potential, and subsequently its reactivity with
H2O2. In chronic inflammatory diseases low molecular
mass metal ion deposits can result from i) compromised
vasculature, ii) the activation of heme oxygenase and iii)
release from storage proteins via superoxide [21]. The Fen-
ton system can generate hydroxyl radicals from the metal
ion activation of H2O2 (eq. 1) [22]. Ascorbic acid can then
recycle Fe(III) to Fe(II) facilitating further generation of
•OH by subsequent Fenton cycles.
Fe(II) + H2O2 → •OH + Fe(III) + OH-  (1)
Weissberger system
Metal ion catalysis of the oxidation of ascorbic acid has
long been an established process for the formation of
H2O2. The reaction was studied in detail initially by
Weissberger et al. (Figure 2) [14] and subsequently by
Martell et al [15]. Although the reaction between ascorbic
acid and oxygen proceeds slowly in the absence of metal
ions, the introduction of redox active metal ions in cata-
Proposed mechanism for the hydroxylation of aromatic moieties by iron ascorbate bindingFigure 2
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very low rate constant for the ascorbic acid auto-oxidation
is reported as 5.87 × 10-4 M-1sec-1 [15]. The catalytic rate in
the presence of Fe(III) is greatly enhanced to 6.4 × 103 M-
1sec-1. Importantly, in the presence of metal ion chelators
other than ascorbic acid the reaction proceeds to give a
Fe(II) complex which would react rapidly with H2O2 to
generate •OH [17]. This generation of toxic •OH from a
simple system containing metal ions, ascorbic acid and
oxygen has potentially deleterious consequences owing to
the ubiquitous nature of these components in diseased
tissues. Under these conditions it is imperative to restrict
ascorbic acid intake to recommended daily intake levels.
Conclusions
Co-supplementation of ferrous salts with vitamin C exac-
erbates oxidative stress in the gastrointestinal tract, predis-
posing individuals to ulceration, inflammatory disorders,
and exacerbation of existing chronic disorders and may
cause cancer.
Iron and ascorbic acid form a potentially toxic cocktail.
Ascorbic acid has been shown to exhibit both anti-oxidant
and pro-oxidant effects in a dose related fashion. The
chemical mechanisms given above have been established
demonstrating the potential for these compounds to
interact and oxidatively damage surrounding tissues. Even
in healthy subjects a positive or negative deviation from
the optimal plasma ascorbic acid level results in oxidative
damage [23]. The detrimental effects of large quantities of
ascorbic acid and iron in healthy subjects and patients
with GI inflammatory diseases warrant further investiga-
tion. In addition dietary supplements containing iron and
ascorbic acid may be deleterious as these components do
not naturally come in concentrated form (as in supple-
mentation tablets).
The evidence for inflammation resulting from the interac-
tion of ferrous ions and ascorbate in animals already
exists. These studies can be extended to humans by
exploiting some of the many studies undertaken on vita-
min and mineral supplementation. A recent study con-
ducted by the Food Standards Agency (UK) is the largest
to date and could be exploited in a follow up to assess the
long term effects of iron and ascorbic acid co-supplemen-
tation [24]. As iron uptake in the GI tract is regulated by
plasma iron levels [25], analysis of plasma iron should
dictate the requirement for iron and vitamin C supple-
mentation to avoid residual iron damaging the GI tract.
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